BioSpace News Archive

Four Productivity Tips for Being More Active in Meetings

Are you worried about your workplace productivity? Don’t worry. Here are four productivity tips to increase your focus in the office and meetings.

October 23, 2018
·
3 min read
·
Porschia Parker
Drug Development

Chi-Med Initiates a Phase I Trial of HMPL-523 in Combination with Azacitidine in Elderly Patients with Acute Myeloid Leukemia in China

Hutchison China MediTech Limited has initiated a Phase I study of HMPL-523, its novel spleen tyrosine kinase (“Syk”) inhibitor, in combination with azacitidine, an approved nucleoside metabolic inhibitor, in elderly patients with acute myeloid leukemia (“AML”) in China.

October 23, 2018
·
4 min read
Business

Celgene Brings in Merck KGaA Vet as Part of an Effort to Fix Clinical Development Woes

Following several clinical disappointments and declining stock prices over the past year, Celgene tapped Alise Reicin as its new head of the company’s global clinical development unit, with a focus on mid- to late-stage therapeutics.

October 23, 2018
·
2 min read
·
Alex Keown
Business

With $50 Million in Upfront Money, Takeda and Enterome Double Down on Crohn’s Disease

Two years after forging a partnership to collaborate on microbiome targets for gastrointestinal disorders, France-based Enterome SA and Takeda Pharmaceuticals have entered into a second agreement. This time with a specific focus on Crohn’s disease.

October 23, 2018
·
3 min read
·
Alex Keown
Job Trends

10 Months After Abandoning Neuroscience R&D, Pfizer Launches CNS Company Cerevel Therapeutics

Pharma giant Pfizer and Bain Capital teamed up to launch Cerevel Therapeutics, a new biopharmaceutical company based in Boston that will focus on developing therapies to treat central nervous system disorders.

October 23, 2018
·
3 min read
·
Alex Keown
Business

Rich in Stem Cells: Umbilical Cord and Cord Blood Therapeutics Gaining Traction - Interview

William H. Tettelbach, deputy chief medical officer of Marietta, Ga.-based MiMedx and lead author of the study, took time to speak with BioSpace about the research, which was published in the International Wound Journal.

October 23, 2018
·
4 min read
·
Mark Terry
Hitachi: Demonstration Operation of ICT System to Improve Efficiency of Energy Use and Medical Care Operations Starts at Indian Hospital

Aim to demonstrate reduction of power consumption by 30% through optimization of energy management

October 23, 2018
·
6 min read
Genetown

Allena Pharmaceuticals Presents Preclinical Data Demonstrating Normalized Urine Uric Acid Excretion and Plasma Urate Reduction Following Treatment with ALLN-346

The data was presented in a poster session on Saturday, October 20, 2018 at the 2018 American College of Rheumatology (ACR/ARHP) Annual Meeting in Chicago, IL

October 23, 2018
·
5 min read
Business

Billionaire Activist Has Invested Over $100 Million for Cheaper Meds

John D. Arnold, a billionaire hedge fund manager who made his fortune on energy stocks, is now taking on the cost of high prescription drugs. The Texas-based Arnold has spent more than $100 million on health-related grants since 2014, with a significant portion dedicated to cheaper medications.

October 23, 2018
·
3 min read
·
Alex Keown
Business

With Money and Equity Changing Hands, Innate Pharma and AstraZeneca Move Deeper into an Immuno-oncology Pact

French company Innate Pharma and UK-based AstraZeneca have had a research collaboration deal in place since 2015. The two companies announced a new multi-term deal to build on that collaboration.

October 23, 2018
·
2 min read
·
Mark Terry